Interpace Biosciences Announces Collaborative Study with University of North Carolina to Assess the Use BarreGENĀ® after Ablation of Dysplastic Barrett's Esophagus

Stock Information for Interpace Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.